Clinical Trial Update: Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the efficacy, safety, and pharmacokinetics of oral paclitaxel in recurrent and metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Oral Paclitaxel (paclitaxel)

Snippet

Sponsor: Daehwa Pharmaceutical Co., Ltd. | Conditions: Recurrent or Metastatic Breast Cancer | Phase 2 | Status: COMPLETED